206 related articles for article (PubMed ID: 31083931)
1. Electrical Impedance Characterization of Erythrocyte Response to Cyclic Hypoxia in Sickle Cell Disease.
Liu J; Qiang Y; Alvarez O; Du E
ACS Sens; 2019 Jul; 4(7):1783-1790. PubMed ID: 31083931
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
[TBL] [Abstract][Full Text] [Related]
3. Rapid electrical impedance detection of sickle cell vaso-occlusion in microfluidic device.
Qiang Y; Dieujuste D; Liu J; Alvarez O; Du E
Biomed Microdevices; 2023 Jun; 25(3):23. PubMed ID: 37347436
[TBL] [Abstract][Full Text] [Related]
4. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE
Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
[TBL] [Abstract][Full Text] [Related]
5. Polymerization and sickle cell disease: a molecular view.
Ferrone FA
Microcirculation; 2004 Mar; 11(2):115-28. PubMed ID: 15280087
[TBL] [Abstract][Full Text] [Related]
6. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
7. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
[TBL] [Abstract][Full Text] [Related]
9. A miniaturized wash-free microfluidic assay for electrical impedance-based assessment of red blood cell-mediated microvascular occlusion.
Oshabaheebwa S; Delianides CA; Patwardhan AA; Evans EN; Sekyonda Z; Bode A; Apio FM; Mutuluuza CK; Sheehan VA; Suster MA; Gurkan UA; Mohseni P
Biosens Bioelectron; 2024 Aug; 258():116352. PubMed ID: 38718635
[TBL] [Abstract][Full Text] [Related]
10. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
Brittenham GM; Schechter AN; Noguchi CT
Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
[TBL] [Abstract][Full Text] [Related]
12. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell biomechanics.
Barabino GA; Platt MO; Kaul DK
Annu Rev Biomed Eng; 2010 Aug; 12():345-67. PubMed ID: 20455701
[TBL] [Abstract][Full Text] [Related]
14. New developments in anti-sickling agents: can drugs directly prevent the polymerization of sickle haemoglobin in vivo?
Oder E; Safo MK; Abdulmalik O; Kato GJ
Br J Haematol; 2016 Oct; 175(1):24-30. PubMed ID: 27605087
[TBL] [Abstract][Full Text] [Related]
15. Faster Sickling Kinetics and Sickle Cell Shape Evolution during Repeated Deoxygenation and Oxygenation Cycles.
Du E; Dao M
Exp Mech; 2019 Mar; 59(3):319-325. PubMed ID: 31178599
[TBL] [Abstract][Full Text] [Related]
16. Effects of nitric oxide and its congeners on sickle red blood cell deformability.
Belanger AM; Keggi C; Kanias T; Gladwin MT; Kim-Shapiro DB
Transfusion; 2015 Oct; 55(10):2464-72. PubMed ID: 25912054
[TBL] [Abstract][Full Text] [Related]
17. Oxidative pathways in the sickle cell and beyond.
Alayash AI
Blood Cells Mol Dis; 2018 May; 70():78-86. PubMed ID: 28554826
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic and molecular insights into sickle cell disease and innovative therapies.
Adebiyi MG; Manalo JM; Xia Y
Blood Adv; 2019 Apr; 3(8):1347-1355. PubMed ID: 31015210
[TBL] [Abstract][Full Text] [Related]
19. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia.
Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI
Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381
[TBL] [Abstract][Full Text] [Related]
20. Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.
Sun K; D'Alessandro A; Ahmed MH; Zhang Y; Song A; Ko TP; Nemkov T; Reisz JA; Wu H; Adebiyi M; Peng Z; Gong J; Liu H; Huang A; Wen YE; Wen AQ; Berka V; Bogdanov MV; Abdulmalik O; Han L; Tsai AL; Idowu M; Juneja HS; Kellems RE; Dowhan W; Hansen KC; Safo MK; Xia Y
Sci Rep; 2017 Nov; 7(1):15281. PubMed ID: 29127281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
